scholarly article | Q13442814 |
P819 | ADS bibcode | 1977PNAS...74.4025B |
P356 | DOI | 10.1073/PNAS.74.9.4025 |
P8608 | Fatcat ID | release_nbrlrlnf2rdexk6lqnj2oqckcy |
P953 | full work available at URL | https://europepmc.org/articles/PMC431828 |
https://europepmc.org/articles/PMC431828?pdf=render | ||
https://pnas.org/doi/pdf/10.1073/pnas.74.9.4025 | ||
P3181 | OpenCitations bibliographic resource ID | 4535459 |
P932 | PMC publication ID | 431828 |
P698 | PubMed publication ID | 198813 |
P5875 | ResearchGate publication ID | 22937735 |
P2093 | author name string | E. P. Benditt | |
N. Eriksen | |||
P2860 | cites work | An Experimental Model in Mink for Studying the Relation Between Amyloid Fibril Protein AA and the Related Serum Protein, SAA | Q46737508 |
A simplified method for the quantitative assay of small amounts of protein in biologic material | Q47967634 | ||
Amino acid sequence of monkey amyloid protein A | Q54327826 | ||
The use of Tween 20 in the double antibody radioimmunoassay | Q67865426 | ||
Enzymatic determination of total serum cholesterol | Q69744405 | ||
The Amino Acid Sequence of a Major Nonimmunoglobulin Component of Some Amyloid Fibrils | Q24594039 | ||
Isolation and partial characterization of SAA-an amyloid-related protein from human serum | Q28610052 | ||
Structure of human serum lipoproteins inferred from compositional analysis | Q35007704 | ||
The primary structure of high density apolipoprotein-glutamine-I | Q35113395 | ||
A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils | Q35901198 | ||
Mouse amyloid protein AA: Homology with nonimmunoglobulin protein of human and monkey amyloid substance | Q35988376 | ||
Chemical classes of amyloid substance | Q36101655 | ||
Immunologic studies of the major nonimmunoglobulin protein of amyloid. I. Identification and partial characterization of a related serum component | Q36272445 | ||
Isolation and identification by sequence analysis of experimentally induced guinea pig amyloid fibrils | Q36273262 | ||
Connective tissue origin of the amyloid-related protein SAA | Q36359988 | ||
Lipoprotein lipase | Q37393065 | ||
"A" protein of amyloidosis. Isolation of a cross-reacting component from serum by affinity chromatography | Q39340681 | ||
Isolation and characterization of amyloid-related serum protein SAA as a low molecular weight protein | Q39352093 | ||
Some properties of antisera to serum amyloid A protein (SAA): inhibition of precipitation by complexing of SAA to albumin | Q39412266 | ||
Amyloidosis: its nature and pathogenesis | Q39868345 | ||
Uptake and degradation of low density lipoprotein by swine arterial smooth muscle cells with inhibition of cholesterol biosynthesis | Q39983246 | ||
Structure of high density lipoprotein. The immunologic reactivities of the COOH- and NH2-terminal regions of apolipoprotein A-I | Q39995959 | ||
High density lipoproteins reduce the uptake of low density lipoproteins by human endothelial cells in culture | Q40000703 | ||
Molecular packing of high density lipoproteins: A postulated functional role | Q40026556 | ||
Immunochemical studies on the nature of the serum component (SAA) related to secondary amyloidosis | Q40882893 | ||
An enzymic method for the trace iodination of immunoglobulins and other proteins | Q42113653 | ||
A molecular theory of lipid-protein interactions in the plasma lipoproteins | Q44498757 | ||
Amyloid A: amphipathic helixes and lipid binding | Q44719267 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | lipoprotein | Q28350 |
P304 | page(s) | 4025-8 | |
P577 | publication date | 1977-09-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Amyloid protein SAA is associated with high density lipoprotein from human serum | |
P478 | volume | 74 |
Q42795983 | A cell culture system for the study of amyloid pathogenesis. Amyloid formation by peritoneal macrophages cultured with recombinant serum amyloid A |
Q39793336 | A comparative approach to secondary amyloidosis |
Q35199639 | A rapid laser immunonephelometric assay for serum amyloid A (SAA) and its application to the diagnosis of kidney allograft rejection |
Q70597091 | A serum AA-like protein as a common constituent of secondary amyloid fibrils |
Q41970760 | AA-amyloidosis. Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product |
Q70293044 | Acid phosphatases bind to the main high density lipoprotein apolipoprotein A-I |
Q73370318 | Acute inflammation, acute phase serum amyloid A and cholesterol metabolism in the mouse |
Q72729119 | Acute-Phase Proteins or Tumour Markers: The Role of SAA, SAP, CRP and CEA as Indicators of Metastasis in a Broad Spectrum of Neoplastic Diseases |
Q41860893 | Acute-phase high-density lipoprotein in the rat does not contain serum amyloid A protein |
Q33389832 | Acute-phase-HDL remodeling by heparan sulfate generates a novel lipoprotein with exceptional cholesterol efflux activity from macrophages |
Q35153889 | Adipose tissue-derived human serum amyloid a does not affect atherosclerotic lesion area in hSAA1+/-/ApoE-/- mice |
Q58298257 | Amino acid sequence analysis of amyloid protein A (AA) from cats (captive cheetahs: Acinonyx jubatus) with a high prevalence of AA amyloidosis |
Q51308059 | Amyloid A Amyloidosis. |
Q36353228 | Amyloid A gene family expression in different mouse tissues |
Q68128411 | Amyloid and amyloidosis |
Q37341069 | Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein |
Q58288735 | Amyloid proteins and amyloidosis in domestic animals |
Q36346022 | Amyloidosis and the serum amyloid A protein response to muramyl dipeptide analogs and different mycobacterial species |
Q28261919 | An Unusually Large (83 Amino Acid Residues) Amyloid Fibril Protein AA from a Patient with Waldenstrom's Macroglobulinaemia and Amyloidosis |
Q50895562 | Analysis of changes in acute-phase plasma proteins in an acute inflammatory response and in rheumatoid arthritis using two-dimensional gel electrophoresis. |
Q68098491 | Antibodies to amyloid A protein in rheumatic diseases |
Q55089258 | Apolipoprotein A-II induces acute-phase response associated AA amyloidosis in mice through conformational changes of plasma lipoprotein structure. |
Q35795491 | Apolipoprotein AI-derived pulmonary vascular amyloid in aged dogs. |
Q72573366 | Association of insulin pump therapy with raised serum amyloid A in type I diabetes mellitus |
Q36985703 | Associations of SAA1 gene polymorphism with lipid lelvels and osteoporosis in Chinese women |
Q37165287 | Avian amyloidosis |
Q33957919 | C-reactive protein and serum amyloid A protein in neonatal infections. |
Q41611055 | Can deposition of amyloid be prevented in Alzheimer's disease? |
Q68442419 | Characterization of Bovine Amyloid Proteins SAA and AA |
Q70539351 | Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA) |
Q28301233 | Characterization of high affinity binding between laminin and the acute-phase protein, serum amyloid A |
Q70999469 | Characterization of human amyloid-related protein SAA as a polymorphic protein: association with albumin and prealbumin in serum |
Q34764150 | Characterization of the oligomerization and aggregation of human Serum Amyloid A |
Q42163690 | Circular-dichroism studies on two murine serum amyloid A proteins |
Q37120248 | Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis |
Q37173276 | Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non-malignant disease |
Q36486571 | Complete primary structures of two major murine serum amyloid A proteins deduced from cDNA sequences |
Q72610612 | Degradation of Protein SAA to an AA-like Fragment by Enzymes of Monocytic Origin |
Q34255078 | Deletion of serum amyloid A3 improves high fat high sucrose diet-induced adipose tissue inflammation and hyperlipidemia in female mice |
Q36342798 | Detection of a mediator derived from endotoxin-stimulated macrohpages that induces the acute phase serum amyloid A response in mice |
Q43245359 | Detection of serum amyloid A isoforms in cattle |
Q70286995 | Diagnosis of the type of amyloid in paraffin wax embedded tissue sections using antisera against human and animal amyloid proteins |
Q42159803 | Differential plasma clearance of murine acute-phase serum amyloid A proteins SAA1 and SAA2 |
Q58274498 | Do alleles at the serum amyloid A locus influence susceptibility to reactive amyloidosis in systemic onset juvenile chronic arthritis? |
Q58265169 | Does serum amyloid A mobilize cholesterol from macrophages during inflammation? |
Q64069819 | Dysfunctional high-density lipoprotein activates toll-like receptors via serum amyloid A in vascular smooth muscle cells |
Q42518227 | Effects of Culture Substrates and Normal Hepatic Sinusoidal Cells on in Vitro Hepatocyte Synthesis of Apo-SAA |
Q41759940 | Effects of serum amyloid A on the structure and antioxidant ability of high-density lipoprotein. |
Q38541225 | Emerging functions of serum amyloid A in inflammation |
Q34186160 | Endotoxin and cytokines increase hepatic messenger RNA levels and serum concentrations of apolipoprotein J (clusterin) in Syrian hamsters |
Q33911023 | Establishment of a transgenic mouse model specifically expressing human serum amyloid A in adipose tissue |
Q73367516 | Evaluation of Feline Serum Amyloid A (SAA) as an Inflammatory Marker |
Q40237161 | Experimental induction of chicken amyloid A amyloidosis in white layer chickens by inoculation with inactivated vaccines |
Q92113184 | Expression of SAA1, SAA2 and SAA4 genes in human primary monocytes and monocyte-derived macrophages |
Q24563622 | Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function |
Q64380188 | Expression of mouse apolipoprotein SAA1.1 in CE/J mice: isoform-specific effects on amyloidogenesis |
Q42159999 | Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis |
Q36356284 | Expression of the third member of the serum amyloid A gene family in mouse adipocytes |
Q71112741 | Familial Mediterranean fever and amyloidosis |
Q44062265 | Fenofibrate inhibits reactive amyloidosis in mice |
Q24527357 | Heterogeneity of human serum amyloid A protein. Five different variants from one individual demonstrated by cDNA sequence analysis |
Q36343838 | Heterogeneity of human serum amyloid A proteins |
Q42859765 | Heterogeneity of serum amyloid A with respect to molecular mass |
Q34002868 | High density lipoprotein, apolipoprotein A-I, and coronary artery disease |
Q40248027 | High-Density Lipoprotein as Carrier for Amyloid-related Protein SAA in Rabbit Serum |
Q33596730 | High-density lipoprotein: multipotent effects on cells of the vasculature. |
Q71407310 | Human glomerular amyloidosis -- with special regard to proteinuria and amyloidogenesis |
Q42074154 | Identification of three isoform patterns of human serum amyloid A protein |
Q70220391 | Immunohistochemical identification of heparan sulphate proteoglycan in secondary systemic amyloidosis |
Q70725835 | Importance of serum amyloid A (SAA) level in monitoring disease activity and response to therapy in patients with prostate cancer |
Q36090984 | Induction of the acute-phase serum protein SAA requires both RNA and protein synthesis |
Q40702838 | Inflammation-associated amyloidogenesis. Lessons for Alzheimer's amyloidogenesis |
Q38543421 | Intrinsic Stability, Oligomerization, and Amyloidogenicity of HDL-Free Serum Amyloid A. |
Q34670833 | Investigation of the solubility and the potentials for purification of serum amyloid A (SAA) from equine acute phase serum--a pilot study |
Q70336051 | Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils? |
Q40767580 | Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus |
Q42936683 | Isolation and characterization of senile amyloid--related antigenic substance (SASSAM) from mouse serum. Apo SASSAM is a low molecular weight apoprotein of high density lipoprotein |
Q36416799 | Isolation and characterization of the amyloid-related apoprotein (SAA) from human high density lipoprotein |
Q42150167 | Isoproteins and an isoelectric focusing mutant of human apoprotein serum amyloid A. |
Q41489696 | Levels of the serum amyloid A protein (SAA) in normal persons of different age groups |
Q41787210 | Major acute-phase reactant synthesis during chronic inflammation in amyloid-susceptible and -resistant mouse strains |
Q34555717 | Measurement of serum amyloid A protein concentrations as test of renal allograft rejection in patients with initially non-functioning grafts |
Q72530546 | Mechanism of reduced amyloid-A-degrading activity in serum of patients with secondary amyloidosis |
Q42640084 | Molecular cloning and sequencing of equine cDNA encoding serum amyloid A (SAA). |
Q70539354 | Monoclonal hybridoma antibodies to human amyloid related protein SAA |
Q36489970 | Morphologic demonstration of cytoplasmic ASSAM-related antigenic substance (CASSAM) by an immunoperoxidase technique |
Q34414931 | Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel |
Q37171830 | Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages |
Q36348480 | Murine tissue amyloid protein AA. NH2-terminal sequence identity with only one of two serum amyloid protein (ApoSAA) gene products |
Q42118250 | Neutrophil association and degradation of normal and acute-phase high-density lipoprotein 3. |
Q68469792 | Non-competitive enzyme-linked immunosorbent assay for human apolipoprotein SAA or S |
Q48300156 | Paradoxical effects of SAA on lipoprotein oxidation suggest a new antioxidant function for SAA. |
Q36997400 | Partial amino acid sequence homology between an heredofamilial amyloid protein and human plasma prealbumin |
Q36562118 | Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2. |
Q41980290 | Phosphorylation of human serum amyloid A protein by protein kinase C. |
Q40984002 | Plasma clearance kinetics of the amyloid-related high density lipoprotein apoprotein, serum amyloid protein (apoSAA), in the mouse. Evidence for rapid apoSAA clearance |
Q40107919 | Plasma protein induction by isolated hepatocytes |
Q33754627 | Polymorphisms in the SAA1/2 Gene Are Associated with Carotid Intima Media Thickness in Healthy Han Chinese Subjects: The Cardiovascular Risk Survey |
Q35448094 | Protein profiling of isolated uterine AA amyloidosis causing fetal death in goats |
Q33752486 | Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function |
Q68789087 | Purification of human serum amyloid A by anion-exchange fast protein liquid chromatography |
Q44846414 | Purification of serum amyloid A and its isoforms from human plasma by hydrophobic interaction chromatography and preparative isoelectric focusing |
Q48198884 | Rabbit Serum Amyloid Protein A: Expression and Primary Structure deduced from cDNA Sequences |
Q33843642 | Rat tissues express serum amyloid A protein-related mRNAs |
Q40075990 | Reactive (secondary) amyloidosis and its pathogenesis |
Q40328402 | Regulation of high density lipoprotein levels |
Q37666992 | Regulation of high-density lipoprotein by inflammatory cytokines: establishing links between immune dysfunction and cardiovascular disease |
Q38362553 | Relationships among the cerebral amyloid peptides and their precursors |
Q70757607 | S-Peptides — new apoproteins of human high density lipoproteins induced by glucose infusions |
Q40333583 | SAA, an apoprotein of HDL: its structure and function |
Q35886240 | SAA: a link between cholesterol efflux capacity and inflammation? |
Q58589906 | Serum Amyloid A3 is required for normal lung development and survival following influenza infection |
Q44750819 | Serum amyloid A (SAA) in viral infection: rubella, measles and subacute sclerosing panencephalitis (SSPE). |
Q74038094 | Serum amyloid A (SAA) protein enhances formation of cyclooxygenase metabolites of activated human monocytes |
Q37209717 | Serum amyloid A (SAA) variations in patients with cancer: correlation with disease activity, stage, primary site, and prognosis |
Q37208763 | Serum amyloid A concentrations during the course of acute ischaemic heart disease |
Q35816880 | Serum amyloid A in the mouse. Sites of uptake and mRNA expression |
Q28298733 | Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2 |
Q41583254 | Serum amyloid A inhibits dendritic cell differentiation by suppressing GM-CSF receptor expression and signaling |
Q33556195 | Serum amyloid A protein (SAA) subtypes in acute and chronic inflammatory conditions |
Q41120880 | Serum amyloid A protein and C-reactive protein levels in pulmonary tuberculosis: relationship to amyloidosis |
Q33839659 | Serum amyloid A protein, apolipoprotein A-I, and apolipoprotein B during the course of acute myocardial infarction |
Q47205995 | Serum amyloid A self-assembles with phospholipids to form stable protein-rich nanoparticles with a distinct structure: A hypothetical function of SAA as a "molecular mop" in immune response |
Q37061136 | Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner |
Q38761950 | Serum amyloid A1: Structure, function and gene polymorphism |
Q40394161 | Serum amyloid A: An acute phase apolipoprotein and precursor of AA amyloid |
Q72530541 | Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis |
Q39243592 | Some effects of the administration of endotoxin in mice. Specific cleavage of serum albumin by an acid protease and the generation of amyloid serum component |
Q89610407 | Structural Basis for Lipid Binding and Function by an Evolutionarily Conserved Protein, Serum Amyloid A |
Q33604867 | Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults |
Q38293426 | Structure of HDL: particle subclasses and molecular components. |
Q36723137 | Structure of serum amyloid A suggests a mechanism for selective lipoprotein binding and functions: SAA as a hub in macromolecular interaction networks. |
Q64882413 | Synergy between serum amyloid A and secretory phospholipase A2. |
Q38677447 | Systemic and cerebral amyloidosis |
Q39536461 | Temperature-Induced Dissociation of Serum Amyloid Protein SAA |
Q72705411 | The acute phase response and its relation to amyloid A degrading activity in serum of patients with rheumatoid arthritis undergoing arthroplasty |
Q58131426 | The acute phase response in Syrian hamsters elevates apolipoprotein serum amyloid A (apoSAA) and disrupts lipoprotein metabolism |
Q28510638 | The acute phase response in apolipoprotein A-1 knockout mice: apolipoprotein serum amyloid A and lipid distribution in plasma high density lipoproteins |
Q40519201 | The molecular basis of reactive amyloidosis |
Q58257518 | The path of murine serum amyloid a through peritoneal macrophages |
Q42820963 | The primary structure of the variable region of an immunoglobin IV light-chain amyloid-fibril protein (AL GIL) |
Q35886290 | Thermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL. |
Q36775267 | Two adjacent C/EBP-binding sequences that participate in the cell-specific expression of the mouse serum amyloid A3 gene |
Q69266475 | Two-dimensional electrophoresis of plasma proteins and high density lipoproteins during inflammation |
Q40625745 | Unifying features of systemic and cerebral amyloidosis |
Q43057974 | Urea-induced denaturation of apolipoprotein serum amyloid A reveals marginal stability of hexamer |
Q40106208 | Widespread extrahepatic expression of acute-phase proteins in healthy chicken (Gallus gallus) tissues. |
Search more.